Results 321 to 330 of about 93,749 (369)
Current Treatment Options in Neurology, 2009 Pituitary adenomas are the most common intrasellar tumors. With the exception of prolactinomas, first-line treatment is almost always surgical. Prolactinomas are usually treated with dopamine agonists such as cabergoline or bromocriptine. Somatostatin analogues, such as octreotide and lanreotide, can be adjunctive to surgical therapy in acromegaly ...
Roberto Salvatori, Nestoras Mathioudakis
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Neurology, 2012
The aim of this article is to review current research in the treatment of pituitary tumors and summarize emerging medical, surgical and radiation-based therapies.Existing medical agents such as dopamine agonists and somatostatin ligand receptors are being used in novel combinations to achieve biochemical remission for pituitary tumors and reduce tumor ...
Gautam U, Mehta, John A, Jane
openaire +2 more sources
The aim of this article is to review current research in the treatment of pituitary tumors and summarize emerging medical, surgical and radiation-based therapies.Existing medical agents such as dopamine agonists and somatostatin ligand receptors are being used in novel combinations to achieve biochemical remission for pituitary tumors and reduce tumor ...
Gautam U, Mehta, John A, Jane
openaire +2 more sources